Telomir pharmaceuticals announces significant reduction of oxidative stress in human retinal cell lines, advancing potential treatment for age-related macular degeneration (amd)

Miami, florida / access newswire / february 18, 2025 / telomir pharmaceuticals, inc. (nasdaq:telo), or telomir, a leader in age-reversal science, today announced groundbreaking results from its recent preclinical studies conducted in human retinal cell lines. these studies demonstrated the ability of telomir-1 to significantly reverse copper and iron-induced elevation of reactive oxygen species (ros).
AMD Ratings Summary
AMD Quant Ranking